It was reported that a patient underwent a cardiac ablation procedure with a thermocool® smart touch¿ electrophysiology catheter for which biosense webster¿s product analysis lab (pal) identified a damage to the pebax.Initially, it was reported that there were no signals on mapping catheter on carto.They exchanged the cable with no improvements.Then, they exchanged the catheter, and the procedure was continued.There was no patient consequence.The signal issue was assessed as non mdr reportable.The potential risk that it could cause or contribute to a serious injury or death to the operator or patient was remote.The biosense webster, inc.Product analysis lab received the device for evaluation and per the evaluation completion on 25-aug-2023, the pebax component was found out of the original place as it was found on the dome.The damage on the pebax was assessed as mdr reportable.The awareness date for this reportable lab finding was 25-aug-2023.
|
E 1.Initial reporter address line 1 (cont.): (b)(6), the product was returned to biosense webster (bwi) for evaluation.A visual inspection and electrical evaluation of the returned device were performed following bwi procedures.Visual analysis revealed that the pebax component was found out of the original place as it was found on the dome.An electrical test was performed, and an open circuit was found in the tip area.The damage on the pebax could be related to the issue reported by the customer.The root cause of the damage on the pebax cannot be determined; however, based on the information available, the condition observed most likely originated in someplace external to the manufacturing environment.All units are inspected prior to leaving the facility as there are functional tests and inspections at control points based on the process flow diagram (pfd) per its part number to avoid this type of damage from leaving the facility.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.The issue reported by the customer was confirmed.It should be noted that product failure is multifactorial.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.This product issue will be addressed through bwi's quality system.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|